NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 16 filers reported holding NEVRO CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,457,918 | -0.4% | 1,574,000 | 0.0% | 0.00% | – |
| Q1 2023 | $1,463,820 | -37.3% | 1,574,000 | -38.9% | 0.00% | – |
| Q4 2022 | $2,335,905 | -54.8% | 2,574,000 | -53.8% | 0.00% | -100.0% |
| Q3 2022 | $5,166,000 | +0.9% | 5,574,000 | +0.1% | 0.00% | 0.0% |
| Q2 2022 | $5,118,000 | -12.8% | 5,568,000 | +0.2% | 0.00% | 0.0% |
| Q1 2022 | $5,869,000 | -5.4% | 5,557,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,206,000 | -30.2% | 5,557,000 | -16.0% | 0.00% | 0.0% |
| Q3 2021 | $8,891,000 | -11.7% | 6,613,000 | +13.8% | 0.00% | 0.0% |
| Q2 2021 | $10,064,000 | +52.4% | 5,811,000 | +33.5% | 0.00% | 0.0% |
| Q1 2021 | $6,605,000 | -9.1% | 4,353,000 | +8.8% | 0.00% | 0.0% |
| Q4 2020 | $7,266,000 | +52.5% | 4,000,000 | +30.3% | 0.00% | 0.0% |
| Q3 2020 | $4,765,000 | -37.5% | 3,069,000 | -44.8% | 0.00% | -50.0% |
| Q2 2020 | $7,624,000 | – | 5,556,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 9,000,000 | $135,324,000 | 1.71% |
| DeepCurrents Investment Group LLC | 21,930,000 | $33,750,000 | 1.16% |
| WOLVERINE ASSET MANAGEMENT LLC | 44,534,000 | $69,564,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,000,000 | $18,208,000 | 0.38% |
| Context Capital Management, LLC | 2,000 | $3,084,000 | 0.30% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $2,276,000 | 0.27% |
| Polar Asset Management Partners Inc. | 17,500,000 | $26,683,000 | 0.26% |
| CSS LLC/IL | 2,500,000 | $3,780,000 | 0.16% |
| Verition Fund Management LLC | 7,486,000 | $11,543,000 | 0.13% |
| PFM Health Sciences, LP | 2,000,000 | $3,032,000 | 0.09% |